 | • レポートコード：MRC2304L055 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、223ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療機器 |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社は、2021年に180.3億ドルであった世界の針なし注射システム市場規模が、2022年に201.7億ドルへと拡大し、その後CAGR 12.00％で成長して2027年までに356.2億ドルに達すると予測しています。当書は、針なし注射システムの世界市場を総合的に分析し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、技術別（ジェット式、レーザー駆動式、ばね式、振動式）分析、製品別（充填可能、充填済み）分析、医薬品種類別（液体ベース、粉末ベース、発射体/デポベース）分析、エンドユーザー別（在宅医療、病院＆クリニック、製薬＆バイオテクノロジー企業、研究所）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報などの項目をまとめています。なお、当書に掲載されている企業情報には、Aijex Pharma International Inc.、Amsino International, Inc.、B. Braun Melsungen AG、Baxter International Inc.、Becton, Dickinson and Company、Covestro AG、Crossject SA、D'Antonio Consultants International, Inc.、Endo International PLCなどが含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の針なし注射システム市場規模：技術別 - ジェット式針なし注射器の市場規模 - レーザー駆動式針なし注射器の市場規模 - ばね式針なし注射器の市場規模 - 振動式針なし注射器の市場規模 ・世界の針なし注射システム市場規模：製品別 - 充填可能針なし注射器の市場規模 - 充填済み針なし注射器の市場規模 ・世界の針なし注射システム市場規模：医薬品種類別 - 液体ベース針なし注射器の市場規模 - 粉末ベース針なし注射器の市場規模 - 発射体/デポベース針なし注射器の市場規模 ・世界の針なし注射システム市場規模：エンドユーザー別 - 在宅医療における市場規模 - 病院＆クリニックにおける市場規模 - 製薬＆バイオテクノロジー企業における市場規模 - 研究所における市場規模 ・世界の針なし注射システム市場規模：地域別 - 南北アメリカの針なし注射システム市場規模 アメリカの針なし注射システム市場規模 カナダの針なし注射システム市場規模 ブラジルの針なし注射システム市場規模 ... - アジア太平洋の針なし注射システム市場規模 日本の針なし注射システム市場規模 中国の針なし注射システム市場規模 インドの針なし注射システム市場規模 韓国の針なし注射システム市場規模 台湾の針なし注射システム市場規模 ... - ヨーロッパ/中東/アフリカの針なし注射システム市場規模 イギリスの針なし注射システム市場規模 ドイツの針なし注射システム市場規模 フランスの針なし注射システム市場規模 ロシアの針なし注射システム市場規模 ... - その他地域の針なし注射システム市場規模 ・競争状況 ・企業情報 |
The Global Needle Free Injection System Market size was estimated at USD 18.03 billion in 2021 and expected to reach USD 20.17 billion in 2022, and is projected to grow at a CAGR 12.00% to reach USD 35.62 billion by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Needle Free Injection System to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Technology, the market was studied across Jet-Based Needle-Free Injectors, Laser-Powered Needle-Free Injectors, Spring-Based Needle-Free Injectors, and Vibration-Based Needle-Free Injectors.
Based on Product, the market was studied across Fillable Needle-Free Injectors and Prefilled Needle-Free Injectors.
Based on Type of Medication, the market was studied across Liquid-based needle free injectors, Powder-based needle free injectors, and Projectile/depot-based needle free injectors.
Based on Usability, the market was studied across Disposable Needle-Free Injectors and Reusable Needle-Free Injectors.
Based on Site of Delivery, the market was studied across Intra dermal injectors, Intramuscular injectors, and Subcutaneous injectors.
Based on End-user, the market was studied across Homecare Settings, Hospitals and Clinics, Pharmaceutical and Biotechnology companies, and Research Laboratories.
Based on Application, the market was studied across Insulin Delivery, Oncology, Pain Management, and Vaccine.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Needle Free Injection System market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Needle Free Injection System Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Needle Free Injection System Market, including Aijex Pharma International Inc., Amsino International, Inc., B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Company, Covestro AG, Crossject SA, D’Antonio Consultants International, Inc., Endo International PLC, European Pharma Group B.V., Ferring B.V., Inovio Pharmaceuticals, Inc., Medical International Technology, Inc., PenJet Corporation, PharmaJet, Inc., Portal Instruments, Inc., and Zogenix, Inc..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Needle Free Injection System Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Needle Free Injection System Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Needle Free Injection System Market?
4. What is the competitive strategic window for opportunities in the Global Needle Free Injection System Market?
5. What are the technology trends and regulatory frameworks in the Global Needle Free Injection System Market?
6. What is the market share of the leading vendors in the Global Needle Free Injection System Market?
7. What modes and strategic moves are considered suitable for entering the Global Needle Free Injection System Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of chronic disease and incidence of communicable disease
5.1.1.2. Increasing demand in drug delivery for biosimilars and vaccination
5.1.1.3. Rising demand for self-injection devices
5.1.2. Restraints
5.1.2.1. High development cost of needle-free injection system
5.1.3. Opportunities
5.1.3.1. Growing prevalence and reported cases of diabetes
5.1.3.2. Integration of advance technology
5.1.4. Challenges
5.1.4.1. Stringent regulations associated with devices
5.2. Cumulative Impact of COVID-19
6. Needle Free Injection System Market, by Technology
6.1. Introduction
6.2. Jet-Based Needle-Free Injectors
6.3. Laser-Powered Needle-Free Injectors
6.4. Spring-Based Needle-Free Injectors
6.5. Vibration-Based Needle-Free Injectors
7. Needle Free Injection System Market, by Product
7.1. Introduction
7.2. Fillable Needle-Free Injectors
7.3. Prefilled Needle-Free Injectors
8. Needle Free Injection System Market, by Type of Medication
8.1. Introduction
8.2. Liquid-based needle free injectors
8.3. Powder-based needle free injectors
8.4. Projectile/depot-based needle free injectors
9. Needle Free Injection System Market, by Usability
9.1. Introduction
9.2. Disposable Needle-Free Injectors
9.3. Reusable Needle-Free Injectors
10. Needle Free Injection System Market, by Site of Delivery
10.1. Introduction
10.2. Intra dermal injectors
10.3. Intramuscular injectors
10.4. Subcutaneous injectors
11. Needle Free Injection System Market, by End-user
11.1. Introduction
11.2. Homecare Settings
11.3. Hospitals and Clinics
11.4. Pharmaceutical and Biotechnology companies
11.5. Research Laboratories
12. Needle Free Injection System Market, by Application
12.1. Introduction
12.2. Insulin Delivery
12.3. Oncology
12.4. Pain Management
12.5. Vaccine
13. Americas Needle Free Injection System Market
13.1. Introduction
13.2. Argentina
13.3. Brazil
13.4. Canada
13.5. Mexico
13.6. United States
14. Asia-Pacific Needle Free Injection System Market
14.1. Introduction
14.2. Australia
14.3. China
14.4. India
14.5. Indonesia
14.6. Japan
14.7. Malaysia
14.8. Philippines
14.9. Singapore
14.10. South Korea
14.11. Taiwan
14.12. Thailand
14.13. Vietnam
15. Europe, Middle East & Africa Needle Free Injection System Market
15.1. Introduction
15.2. Denmark
15.3. Egypt
15.4. Finland
15.5. France
15.6. Germany
15.7. Israel
15.8. Italy
15.9. Netherlands
15.10. Nigeria
15.11. Norway
15.12. Poland
15.13. Qatar
15.14. Russia
15.15. Saudi Arabia
15.16. South Africa
15.17. Spain
15.18. Sweden
15.19. Switzerland
15.20. Turkey
15.21. United Arab Emirates
15.22. United Kingdom
16. Competitive Landscape
16.1. FPNV Positioning Matrix
16.1.1. Quadrants
16.1.2. Business Strategy
16.1.3. Product Satisfaction
16.2. Market Ranking Analysis, By Key Player
16.3. Market Share Analysis, By Key Player
16.4. Competitive Scenario
16.4.1. Merger & Acquisition
16.4.2. Agreement, Collaboration, & Partnership
16.4.3. New Product Launch & Enhancement
16.4.4. Investment & Funding
16.4.5. Award, Recognition, & Expansion
17. Company Usability Profiles
17.1. Aijex Pharma International Inc.
17.1.1. Business Overview
17.1.2. Key Executives
17.1.3. Product & Services
17.2. Amsino International, Inc.
17.2.1. Business Overview
17.2.2. Key Executives
17.2.3. Product & Services
17.3. B. Braun Melsungen AG
17.3.1. Business Overview
17.3.2. Key Executives
17.3.3. Product & Services
17.4. Baxter International Inc.
17.4.1. Business Overview
17.4.2. Key Executives
17.4.3. Product & Services
17.5. Becton, Dickinson and Company
17.5.1. Business Overview
17.5.2. Key Executives
17.5.3. Product & Services
17.6. Covestro AG
17.6.1. Business Overview
17.6.2. Key Executives
17.6.3. Product & Services
17.7. Crossject SA
17.7.1. Business Overview
17.7.2. Key Executives
17.7.3. Product & Services
17.8. D’Antonio Consultants International, Inc.
17.8.1. Business Overview
17.8.2. Key Executives
17.8.3. Product & Services
17.9. Endo International PLC
17.9.1. Business Overview
17.9.2. Key Executives
17.9.3. Product & Services
17.10. European Pharma Group B.V.
17.10.1. Business Overview
17.10.2. Key Executives
17.10.3. Product & Services
17.11. Ferring B.V.
17.11.1. Business Overview
17.11.2. Key Executives
17.11.3. Product & Services
17.12. Inovio Pharmaceuticals, Inc.
17.12.1. Business Overview
17.12.2. Key Executives
17.12.3. Product & Services
17.13. Medical International Technology, Inc.
17.13.1. Business Overview
17.13.2. Key Executives
17.13.3. Product & Services
17.14. PenJet Corporation
17.14.1. Business Overview
17.14.2. Key Executives
17.14.3. Product & Services
17.15. PharmaJet, Inc.
17.15.1. Business Overview
17.15.2. Key Executives
17.15.3. Product & Services
17.16. Portal Instruments, Inc.
17.16.1. Business Overview
17.16.2. Key Executives
17.16.3. Product & Services
17.17. Zogenix, Inc.
17.17.1. Business Overview
17.17.2. Key Executives
17.17.3. Product & Services
18. Appendix
18.1. Discussion Guide
18.2. License & Pricing